The group’s principal activity is to provide pharmaceutical services. The group also focused on developing, acquiring and commercializing products. The group’s products include Desonate, Vaniqa, EpiQuin micro and NeoBenz micro. The group operates from the United States.
Executive Information
Name
Title
Email
Richard Fitzpatrick
Founder, Chmn., Member - Scientific Advisory Board
